Cargando…

Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

IMPORTANCE: The antifungal medication voriconazole is used to prevent and treat aspergillosis, a major cause of mortality among recipients of lung transplants (hereinafter referred to as lung recipients). Small studies suggest that voriconazole increases risk of cutaneous squamous cell carcinoma (SC...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Arcy, Monica E., Pfeiffer, Ruth M., Rivera, Donna R., Hess, Gregory P., Cahoon, Elizabeth K., Arron, Sarah T., Brownell, Isaac, Cowen, Edward W., Israni, Ajay K., Triplette, Matthew A., Yanik, Elizabeth L., Engels, Eric A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221851/ https://www.ncbi.nlm.nih.gov/pubmed/32401271 http://dx.doi.org/10.1001/jamadermatol.2020.1141

Ejemplares similares

Risk of Rare Cancers Among Solid Organ Transplant Recipients
por: D’Arcy, Monica E, et al.
Publicado: (2020)

Melanoma risk and survival among organ transplant recipients
por: Robbins, Hilary A., et al.
Publicado: (2015)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients
por: Engels, Eric A., et al.
Publicado: (2018)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Voriconazole-induced Myositis in a Double Lung Transplant Recipient
por: Soliman, Mohanad, et al.
Publicado: (2019)

Coronavirus disease-19 mortality among solid organ transplant recipients in the United States during June and December 2020: Comparison of Organ Procurement and Transplantation Network and National Death Index data
por: Volesky-Avellaneda, Karena D., et al.
Publicado: (2023)

Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2018)

Exposed hardware in a patient with invasive keratinocyte carcinoma
por: Gao, Yi, et al.
Publicado: (2017)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
por: Zhao, Yi‐Chang, et al.
Publicado: (2020)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
por: Zhao, Yi-Chang, et al.
Publicado: (2022)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned
por: Zhang, Shali, et al.
Publicado: (2015)

Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2022)

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum
por: Luijk, B., et al.
Publicado: (2011)

Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient
por: PACCOUD, Olivier, et al.
Publicado: (2023)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Disseminated Trichosporon asahii infection in a combined liver‐kidney transplant recipient successfully treated with voriconazole
por: Sah, Ranjit, et al.
Publicado: (2019)

Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
por: Li, Zi-Wei, et al.
Publicado: (2017)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis
por: Yanik, Elizabeth L, et al.
Publicado: (2015)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Real-World Experience of Voriconazole Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Single-Center Study
por: Chan, Shuk-Ying, et al.
Publicado: (2017)

A case of Exophiala oligosperma successfully treated with voriconazole()
por: Rimawi, Bassam H., et al.
Publicado: (2013)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
por: Liang, Zaiming, et al.
Publicado: (2022)

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
por: Cheng, Lin, et al.
Publicado: (2023)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
por: Van Daele, Ruth, et al.
Publicado: (2021)

Rechallenge of voriconazole successfully tolerated after hepatic toxicity
por: Narumoto, O., et al.
Publicado: (2020)

Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study
por: Hikasa, Shinichi, et al.
Publicado: (2020)

Successful treatment of Chrysosporium keratitis with voriconazole
por: Thanathanee, Onsiri, et al.
Publicado: (2017)

Comparison of clinical pharmacology of voriconazole and posaconazole
por: Sienkiewicz, Beata M., et al.
Publicado: (2016)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Successful management of presumed Candida endogenous endophthalmitis with oral voriconazole
por: Biju, Raju, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a9k50ng0lp5jp6qi1grgf26rvu